Evidence map›Paper›PMID 32856173›Full record

ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2020

The Regenerative Effect of Trans-spinal Magnetic Stimulation After Spinal Cord Injury: Mechanisms and Pathways Underlying the Effect.

C Chalfouh, C Guillou, J Hardouin, Q Delarue, X Li, C Duclos, D Schapman, J-P Marie, P Cosette, N Guérout

Open access · hybridAbstract read
In one paragraph

Article in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

C ChalfouhNormandie Univ, UNIROUEN, EA3830 GRHV, 76000, Rouen, France. chalfouhchaima@gmail.com.
C GuillouPISSARO Proteomic Facility, Normandie Univ, UNIROUEN, 76821, Mont-Saint-Aignan, France.
J HardouinPISSARO Proteomic Facility, Normandie Univ, UNIROUEN, 76821, Mont-Saint-Aignan, France.
Q DelarueNormandie Univ, UNIROUEN, EA3830 GRHV, 76000, Rouen, France.
X LiDepartment of Neurobiology, Care sciences and Society, BioClinicum, Karolinska Institutet, 17164, Stockholm, Sweden.
C DuclosNormandie Univ, UNIROUEN, EA3830 GRHV, 76000, Rouen, France.
D SchapmanInstitute for Research and Innovation in Biomedicine (IRIB), Mont-Saint-Aignan, France.
J-P MarieNormandie Univ, UNIROUEN, EA3830 GRHV, 76000, Rouen, France.
P CosettePISSARO Proteomic Facility, Normandie Univ, UNIROUEN, 76821, Mont-Saint-Aignan, France.
N GuéroutNormandie Univ, UNIROUEN, EA3830 GRHV, 76000, Rouen, France. nicolas.guerout@univ-rouen.fr.
Institute for Research and Innovation in Biomedicine · FRKarolinska Institutet · SENormandie Université · FRUniversité de Rouen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinal cord injury (SCI) leads to a loss of sensitive and motor functions. Currently, there is no therapeutic intervention offering a complete recovery. Here, we report that repetitive trans-spinal magnetic stimulation (rTSMS) can be a noninvasive SCI treatment that enhances tissue repair and functional recovery. Several techniques including immunohistochemical, behavioral, cells cultures, and proteomics have been performed. Moreover, different lesion paradigms, such as acute and chronic phase following SCI in wild-type and transgenic animals at different ages (juvenile, adult, and aged), have been used. We demonstrate that rTSMS modulates the lesion scar by decreasing fibrosis and inflammation and increases proliferation of spinal cord stem cells. Our results demonstrate also that rTSMS decreases demyelination, which contributes to axonal regrowth, neuronal survival, and locomotor recovery after SCI. This research provides evidence that rTSMS induces therapeutic effects in a preclinical rodent model and suggests possible translation to clinical application in humans.

Indexed as

Age FactorsAnimalsCells, CulturedFemaleMagnetic Field TherapyMaleMiceMice, Inbred C57BLMice, TransgenicNerve RegenerationSpinal Cord InjuriesSpinal Cord StimulationThoracic Vertebraeglial scarmagnetic stimulation and neuroregenerationRehabilitationspinal cord injury

Identifiers

PMID32856173
PMCPMC7851265
OpenAlexW3082730857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.